Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Tea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy

Fig. 1

Schematic illustration of preparation and mechanism of hNVs@Flu-EGCG. (A) EGCG-modified cell membranes-derived nanoparticles are used as vehicles for targeted delivery of Flu. (B) The hNVs@Flu-EGCG target tumor sites, reprogramme M2 macrophages to M1 macrophages, act on androgen receptors to inhibit tumor proliferation, promote apoptosis by inhibiting the NF-κB pathway, reduce PSA level in the body, improve tumor drug resistance and enhance combination therapy

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us